LinkedInXFacebook
Subscribe
Orthopedics This Week
  • My Feed
  • |Posts
  • |Events
  • |MSK Innovations
  • |Power Rankings
  • |Masterclasses
  • |Technology Awards
  • Press Releases
  • |Advertising
  • |Job Board
  • Spine
  • ◆Joints
  • ◆Upper Extremities
  • ◆Foot & Ankle
  • ◆Sports Medicine
  • ◆Pain Mgmt
  • ◆Trauma
  • ◆Biologics
  • ◆Technology
  • ◆People
  • ◆Company News
  • ◆Legal & Regulatory
Home/Large Joints and Extremities/Solving a Controversy in Pediatric Developmental Hip Dislocation?
Large Joints and Extremities

Solving a Controversy in Pediatric Developmental Hip Dislocation?

August 25, 2020 2 min read Premium comments

Advertisement

Solving a Controversy in Pediatric Developmental Hip Dislocation?
Source: Wikimedia Commons and Ilya Haykinson
Secondary#openreduction#closedreduction#salterinnominateosteotomy

For little pediatric patients—at least 18 months old—the initial treatment for developmental hip dislocation is not without controversy. Noting that single-stage open reduction and pelvic osteotomy is aggressive, a group of surgeons from the University of Iowa in Iowa City set out to compare dislocated hips treated with closed reduction to those treated with open reduction and Salter innominate osteotomy. Results were presented at the Pediatric Orthopaedic Society of North America Annual Meeting.

Co-author Stuart L. Weinstein, M.D., a past president of the Pediatric Orthopedic Society of North America, told OTW, “At Iowa we have a long standing tradition of following children with various musculoskeletal conditions long term to either determine the natural history of the condition or to determine the outcomes of standard treatments of a condition to see if natural history has been favorably altered. For a number of years we have been following a large number of children with developmental hip dysplasia treated only by closed reduction. We began to see the development of hip osteoarthritis developing in these patients in young and mid adult life.”

“In children diagnosed after 18 months of age there was a cohort treated at the Hospital for Sick Children in Toronto, Canada, in the same era but by a more aggressive approach; open reduction accompanied by innominate osteotomy and followed long term. We hence decided to take the unique opportunity to estimate the relative hazard of total hip arthroplasty and the total hip free survival time in children treated by these two methods between 18 and 36 months of age.”

The team looked at 45 patients (58 hips) ages 18-60 months who underwent CR [closed reduction] and 58 patients (78 hips) of similar ages who were treated with open reduction and Salter innominate osteotomy.

Dr. Weinstein: “Those of us who treat DDH have learned from personal experience and the literature that the only way to guarantee good long term outcomes in developmental hip dysplasia is to detect it in the nursery. Late diagnosed developmental hip [DDH] dysplasia puts the hip at risk for developing osteoarthritis at an early age. What was surprising was the similarity in survival analysis in both treatment groups.”

He told OTW, “At 48 years of follow-up, 29 (50%) of the hips survived after closed reduction compared with 54 (69%) after open reduction and Salter innominate osteotomy. At 45 years, the survival probability after open reduction and Salter innominate osteotomy was 0.63 (95% confidence interval [CI] = 0.50 to 0.78) compared with 0.55 (95% CI = 0.43 to 0.72) after closed reduction. Both treatments provided substantial benefit relative to the natural history of DDH, but THA [total hip arthroplasty] is the expected outcome in middle adulthood.”

Co-author Lori Dolan, Ph.D. added,“I would emphasize that this was a unique opportunity to perform a comparative effectiveness study, which only came about because Simon, et al. published the raw data in the Appendix to their article. It is also extremely rare that two centers would have reliable serial data to characterize both the treatment and the long-term outcomes of a cohort of pediatric patients.”

React:

Discussion

14
DS
Dr. Sarah MitchellOrthopedic Surgeon · Mayo Clinic

This is a fascinating development. In my practice we've seen similar outcomes with the revised protocol. The key differentiator seems to be patient selection criteria. Has anyone else noticed the correlation with BMI thresholds?

8
JT
James Thornton, MDSpine Fellow · HSS

Great point. I'd push back slightly on the conclusion, the sample size in the cited study is too small to draw population-level inferences. That said, the directional signal is compelling and worth a larger RCT.

5
RP
R. PatelSports Medicine · Stanford

We implemented a similar approach last year. Early results are promising but we're still gathering 12-month follow-up data. Happy to share our protocol if anyone is interested.

Join the conversation

Orthopedic professionals are discussing this. Sign in and upgrade to read every comment and add your voice.

Subscribe

Get Full Access

Read every OTW article and join member discussions for $24.99/month.

Get Full Access

Advertisement

Advertisement

Advertisement

Orthopedics This Week

The most trusted source in orthopedic industry news since 2005. Covering spine, joints, trauma, biologics, and the business of orthopedics.

A publication of RRY Publications, LLC

LinkedInXFacebook

Categories

  • Spine
  • Joints
  • Upper Extremities
  • Foot & Ankle
  • Sports Medicine
  • Pain Mgmt
  • Trauma
  • Biologics
  • Technology
  • People
  • Company News
  • Legal & Regulatory

Resources

  • Subscribe
  • Community Posts
  • Job Board
  • Press Release Opportunities
  • Power Rankings
  • About OTW
  • Advertise
  • Contact Us

Get Full Access

Unlimited articles, community posts, and Power Rankings.

Get Full Access

Plans start at $24.99/mo · Annual saves 20%

© 2026 Orthopedics This Week · RRY Publications, LLC

Privacy PolicyTerms of ServiceCookie Policy